[Vulvovaginal candidiasis]

Klin Mikrobiol Infekc Lek. 2015 Sep;21(3):74-81.
[Article in Czech]

Abstract

Vulvovaginal candidiasis is the second most common vaginal infection after bacterial vaginosis. It is caused by yeasts, the vast majority of which belong to the genus Candida. Vulvovaginal candidiasis affects as many as 75 % of women during their childbearing years and 40 % of them experience recurrences. The most common etiological agent is Candida albicans, which is responsible for nearly 90 % of cases. Vulvovaginal candidiasis can be treated with topical and/or systemic antifungals while risk factors for the infection must be eliminated.

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Candida albicans / physiology*
  • Candidiasis, Vulvovaginal / drug therapy
  • Candidiasis, Vulvovaginal / epidemiology
  • Candidiasis, Vulvovaginal / microbiology*
  • Female
  • Humans
  • Recurrence
  • Risk Factors

Substances

  • Antifungal Agents